122 related articles for article (PubMed ID: 4650517)
41. [Relation between sulfobromophthalein Au-198 clearance and scintigraphic aspects in hepatopathies].
Maduli S; Castagnetti GL
G Clin Med; 1970 Mar; 51(3):180-256. PubMed ID: 5477744
[No Abstract] [Full Text] [Related]
42. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection.
Giannini E; Botta F; Borro P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Mamone M; Testa R
Am J Gastroenterol; 2003 Nov; 98(11):2516-20. PubMed ID: 14638357
[TBL] [Abstract][Full Text] [Related]
43. [Intravenous galactose tolerance test as liver function test].
Rommel K; Böhmer R; Adam WE
Schweiz Med Wochenschr; 1967 Apr; 97(15):484-7. PubMed ID: 5585388
[No Abstract] [Full Text] [Related]
44. Letter: High-dose bromsulphalein clearance test.
Sereny G; Kalant H; Endrenyi L
J Med; 1973; 4(3):193-4. PubMed ID: 4520759
[No Abstract] [Full Text] [Related]
45. [Roral galactose tolerance test].
Hayashi T; Yamaguchi H; Matsui K
Rinsho Byori; 1971 Jan; 19(1):10-3. PubMed ID: 5103824
[No Abstract] [Full Text] [Related]
46. [Renal function in diffuse hepatopathies].
León Castro J; Barranco Jiménez M
Rev Clin Esp; 1971 May; 121(4):339-46. PubMed ID: 5563109
[No Abstract] [Full Text] [Related]
47. [Diagnostic value of the combined BSP-indocyanine green test with continuous recording].
Lemonnier F; Chevrel B; Caroli J
Pathol Biol (Paris); 1969; 17(15):687-95. PubMed ID: 4907900
[No Abstract] [Full Text] [Related]
48. [Caffeine--an ubiquitous indicator of liver function].
Renner E; Wahländer A; Huguenin P; Wietholtz H; Preisig R
Schweiz Med Wochenschr; 1983 Aug; 113(31-32):1074-81. PubMed ID: 6623026
[No Abstract] [Full Text] [Related]
49. [Clinical value of the Bauer test with the Ludvig-Streller modification in the study of the carbohydrate function of the liver].
Belov GF
Lab Delo; 1969; 1():3-4. PubMed ID: 4185358
[No Abstract] [Full Text] [Related]
50. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation of the hepatocyte.
Tygstrup N; Vilstrup H
Lab Res Methods Biol Med; 1983; 7():17-41. PubMed ID: 6353103
[No Abstract] [Full Text] [Related]
52. [Examination of intravenous galactose loading test. 2].
Fukui I; Soyama H; Ono E; Yoshida T; Takino TT
Rinsho Byori; 1971 Aug; 19():Suppl:390. PubMed ID: 5168078
[No Abstract] [Full Text] [Related]
53. [Absorption of vofaverdin by the liver in circulatory insufficiency, chronic hepatitis and liver cirrhosis].
Fomichev VI
Klin Med (Mosk); 1973 Oct; 51(10):94-6. PubMed ID: 4787288
[No Abstract] [Full Text] [Related]
54. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.
Everson GT; Shiffman ML; Morgan TR; Hoefs JC; Sterling RK; Wagner DA; Kulig CC; Curto TM; Wright EC;
Aliment Pharmacol Ther; 2008 May; 27(9):798-809. PubMed ID: 18266997
[TBL] [Abstract][Full Text] [Related]
55. [The behavior of hepatic blood flow determined by clearance of radio-colloids in senile subjects with chronic hepatitis and hepatic cirrhosis].
Tesauro P; Manduca A; Corsini GC; De Gaetano M; Cicala V
G Gerontol; 1969 Jul; 17(7):721-8. PubMed ID: 4908857
[No Abstract] [Full Text] [Related]
56. [Contribution to the study of splenic function in patients with chronic hepatitis and splenomegalic cirrhosis].
Gheorghescu B; Jovin G; Merculiev E; Timiş E; Mardale D
Stud Cercet Med Interna; 1966; 7(6):615-20. PubMed ID: 5962831
[No Abstract] [Full Text] [Related]
57. [Liver function studies with 131-I-bromsulphalein (author's transl)].
Strötges MW; Nehen HG; Heissen E
Leber Magen Darm; 1973 Dec; 3(6):257-60. PubMed ID: 4785772
[No Abstract] [Full Text] [Related]
58. [The BSP purification tests].
Chevrel B
Presse Med (1893); 1969 Apr; 77(18):682. PubMed ID: 5790092
[No Abstract] [Full Text] [Related]
59. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
[TBL] [Abstract][Full Text] [Related]
60. [Comparative evaluation of the dyes bromsulphthalein and indocyanine green in liver function diagnosis].
Andree H; Berndt H
Z Arztl Fortbild (Jena); 1984; 78(22):931-6. PubMed ID: 6528633
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
